Phorbol-12,13-dibutyrate improves the quality of cytogenetic preparation in lymphoid malignancies.
In cytogenetic preparation of lymphoid malignancies we investigated the quantitative and qualitative impact of phorbol-12,-13-dibutyrate (P) and of this tumor promoter in combination with the calcium ionophore A23187 (PA). Using parallel cultures of unstimulated and stimulated preparations, the effect was examined in 13 patients with malignant lymphomas and six patients with acute lymphoblastic leukemias (ALL). Focusing on high-quality analyzable metaphases, the best results were found in seven of 13 cases with lymphomas and five of six patients with ALL in the cultures supplemented with phorbol-12,13-dibutyrate. The yield of metaphases of good quality regarding length, spreading, and banding of chromosomes was regularly better in P-stimulated 24-hour culture (p < 0.05), followed by 48-hour cultures stimulated with P alone. Addition of the calcium-ionophore was of no further benefit. The yield of the unstimulated direct harvest was rather poor in nearly all patients investigated. Because no mutagenic effect of P was observed, the use of this mitogen may offer interesting perspectives in cytogenetic analysis of lymphoid malignancies and perhaps also in other tumors with low mitotic indexes.
Pirc-Danoewinata
H
H
Division of Oncology, University of Vienna, Austria.
Onderka
E
E
Porenta
G
G
Kundi
M
M
Nowotny
H
H
Schlögl
E
E
Heinz
R
R
Kreiner
G
G
Marosi
C
C
D000001:Calcimycin / Q000494:pharmacology; D002869:Chromosome Aberrations; D003582:Cytogenetics / Q000379:methods*; D005260:Female; D006801:Humans; D007202:Indicators and Reagents; D008223:Lymphoma / Q000235:genetics*; D008297:Male; D008677:Metaphase / Q000187:drug effects; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology
D007202:Indicators and Reagents; D015240:Phorbol 12,13-Dibutyrate; D000001:Calcimycin